Monday, 6 July 2026Live global desk
GlobalPulse
The world, tracked in motion
Health

Bryan Johnson diagnosed incurable disease

Millionaire biohacker Bryan Johnson has revealed a diagnosis of Autoimmune Gastritis, a condition where the immune system attacks the stomach lining.

Bryan Johnson diagnosed incurable disease
Bryan Johnson diagnosed incurable disease

Bryan Johnson diagnosed incurable disease

Bryan Johnson, a 48-year-old millionaire biohacker, has been diagnosed with an incurable autoimmune disease called Autoimmune Gastritis (AIG). Johnson, who is known for his efforts to "defeat death" and reverse the aging process, revealed his diagnosis on social media, stating that his "stomach is eating itself."

According to Johnson, AIG affects between 2 to 5% of people, although it may be more prevalent due to its difficulty in diagnosis. The disease causes the immune system to attack the stomach lining, leading to irreversible damage, nutritional deficiency, anemia, and an increased risk of cancer.

Johnson's journey to diagnosis was a long one. He was first diagnosed with hypothyroidism at the age of 21 and had been managing the condition with medication for nearly three decades. However, he began to experience other health issues, including chronic depression and weight gain, which he attributes to his poor diet and lifestyle as a child and young adult.

Despite his efforts to maintain a healthy lifestyle, Johnson's ferritin levels remained low, even after taking iron supplements. It wasn't until he underwent a series of medical tests, including a colonoscopy, endoscopy, and biopsies, that he was finally diagnosed with AIG.

The diagnosis has not deterred Johnson, who has vowed to "try and solve" the condition. He and his medical team plan to conduct routine monitoring of his iron levels and other biological indicators, as well as perform additional tests to understand more about the disease. Depending on the findings, they will implement "experimental approaches" to manage the condition, including targeting proteins that act as chemical messengers in the immune system and rebuilding regulatory T-cells.

Some have questioned the effectiveness of his approaches, which are based on "investigational preclinical evidence at best." However, Johnson remains hopeful that he can find a way to manage the condition and potentially even cure it.

AIG, in particular, is often asymptomatic in its early stages, making it difficult to diagnose.

As Johnson continues to navigate his diagnosis and treatment, he remains committed to his goal of "defeating death" and reversing the aging process. His efforts have garnered a significant following on social media. As Johnson himself said, "In the age of AI, multiomics, and custom-built DNA, proteins, and cells, no condition should be presumed incurable simply because no one has yet tried to cure it with today's stack."

What's next for Bryan Johnson?

Johnson's team will continue to monitor his condition and implement experimental approaches to manage the disease. He will also share his progress and findings with his followers.

Reporting based on coverage by dailymail.com.

Related stories